U.S. lawmakers seek HELP for nebulous 340B Drug Discount program

The finger pointing over U.S. drug prices continued Tuesday as members of the Senate Health, Education, Labor and Pensions (HELP) Committee once again tried to grope their way through the nebulous fog of the 340B Discount Drug program.

Continue reading on BioWorld.